Predictive value of oxidative stress biomarkers in drug-free patients with bipolar disorder

References

• Grande I, Berk M, Birmaher B, et al. Bipolar disorder. The Lancet. 2016;387(10027):1561–1572.
   PubMed Web of Science ®Google Scholar
• Charlson FJ, Baxter AJ, Dua T, et al. Excess mortality from mental, neurological, and substance use disorders in the global burden of disease study 2010. In: Disease control priorities. Third Edition (Volume 4): Mental, Neurological, and Substance Use Disorders; 2016. https://doi.org/10.1596/978-1-4648-0426-7_ch3.
   Google Scholar
• Sagar R, Pattanayak RD. Potential biomarkers for bipolar disorder: Where do we stand? Indian J Med Res. 2017;145(1):7.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Noronha Frey B, Erdtmann B, et al. DNA damage in bipolar disorder. Psychiatry Res. 2007;153(1):27–32.
   PubMed Web of Science ®Google Scholar
• Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804–817.
   PubMed Web of Science ®Google Scholar
• Frey BN, Andreazza AC, Houenou J, et al. Biomarkers in bipolar disorder: a positional paper from the international society for bipolar disorders biomarkers task force. Aust NZ J Psychiatry. 2013;47(4):321–332.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675–692.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosc. 2009;34(4):263–271.
   PubMed Web of Science ®Google Scholar
• Cingi Yirun M, Unal K, Altunsoy Sen N, et al. Evaluation of oxidative stress in bipolar disorder in terms of total oxidant status, total antioxidant status, and oxidative stress index. Arch Neuropsychiatr. 2016;53(3):194–198.
   Google Scholar
• Muneer A. The neurobiology of bipolar disorder: an integrated approach. Chonnam Med J. 2016;52(1):18–37.
   PubMedGoogle Scholar
• Raffa M, Barhoumi S, Atig F, et al. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(2):371–375.
   PubMed Web of Science ®Google Scholar
• de Sousa RT, Zarate CA, Zanetti MV, et al. Oxidative stress in early stage bipolar disorder and the association with response to lithium. J Psychiatr Res. 2014;50:36–41.
   PubMed Web of Science ®Google Scholar
• Kuloglu M, Ustundag B, Atmaca M, et al. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002;20(2):171–175.
   PubMed Web of Science ®Google Scholar
• Kunz M, Gama CS, Andreazza AC, et al. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32(7):1677–1681.
   PubMed Web of Science ®Google Scholar
• Jiménez-Fernández S, Gurpegui M, Garrote-Rojas D, et al. Oxidative stress parameters and antioxidants in patients with bipolar disorder: results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar Disord. 2021;23(2):117–129.
   PubMed Web of Science ®Google Scholar
• Akarsu S, Bolu A, Aydemir E, et al. The relationship between the number of manic episodes and oxidative stress indicators in bipolar disorder. Psychiatry Investig. 2018;15(5):514–519.
   PubMed Web of Science ®Google Scholar
• Grintzalis K, Zisimopoulos D, Grune T, et al. Method for the simultaneous determination of free/protein malondialdehyde and lipid/protein hydroperoxides. Free Radic Biol Med. 2013;59:27–35.
   PubMed Web of Science ®Google Scholar
• Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 2014;218(1–2):61–68.
   PubMed Web of Science ®Google Scholar
• Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;Volume 13:757–772.
   Web of Science ®Google Scholar
• Kashihara N, Haruna Y, Kondeti VK, et al. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17(34):4256–4269.
   PubMed Web of Science ®Google Scholar
• Smith MA, Sayre LM, Anderson VE, et al. Cytochemical demonstration of oxidative damage in alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4- dinitrophenylhydrazine. J Histochem Cytochem. 1998;46(6):731–735.
   PubMed Web of Science ®Google Scholar
• Keeney PM, Xie J, Capaldi RA, et al. Parkinson’s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci. 2006;26(19):5256–5264.
   PubMed Web of Science ®Google Scholar
• Dal-Pont GC, Resende WR, Varela RB, et al. Inhibition of GSK-3β on behavioral changes and oxidative stress in an animal model of mania. Mol Neurobiol. 2019;56(4):2379–2393.
   PubMed Web of Science ®Google Scholar
• Gawryluk JW, Wang JF, Andreazza AC, et al. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol. 2011;14(1):123–130.
   PubMed Web of Science ®Google Scholar
• Rosa AR, Singh N, Whitaker E, et al. Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels. Psychol Med. 2014;44(11):2409–2418.
   PubMed Web of Science ®Google Scholar
• Ezzaher A, Mouhamed DH, Mechri A, et al. Hyperhomocysteinemia in tunisian bipolar i patients. Psychiatry Clin Neurosci. 2011;65(7):664–671., ).
   PubMed Web of Science ®Google Scholar
• Olas B, Kedzierska M, Wachowicz B. Comparative studies on homocysteine and its metabolite – homocysteine thiolactone action in blood platelets in vitro. Platelets. 2008;19(7):520–527.
   PubMed Web of Science ®Google Scholar
• Carluccio MA, Ancora MA, Massaro M, et al. Homocysteine induces VCAM-1 gene expression through NF-κB and NAD(P)H oxidase activation: protective role of mediterranean diet polyphenolic antioxidants. Am J Physiol – Heart Circ Physiol. 2007;293(4):H2344–H2354.
   PubMed Web of Science ®Google Scholar
• Dietrich-Muszalska A, Malinowska J, Olas B, et al. The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients. Neurochem Res. 2012;37(5):1057–1062.
   PubMed Web of Science ®Google Scholar
• Padovani D. A new link between high homocysteine levels, cancers and neurodegenerative diseases. Medecine/Sci. 2017;2017:12.
   Google Scholar
• Perła-Kaján J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids. 2007;32(4):561–572.
   PubMed Web of Science ®Google Scholar
• Rowland T, Perry BI, Upthegrove R, et al. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. Br J Psychiatry. 2018;213(3):514–525.
   PubMed Web of Science ®Google Scholar
• Tandon R, Gaebel W, Barch DM, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013;150(1):3–10.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.
   PubMed Web of Science ®Google Scholar
• Hobson J. The montreal cognitive assessment (MoCA). Occup Med. 2015;65(9):764–765.
   Google Scholar
• Licht RW, Jensen J. Validation of the Bech-Rafaelsen mania scale using latent structure analysis. Acta Psychiatr Scand. 1997;96(5):367–372.
   PubMed Web of Science ®Google Scholar
• Soron TR. Validation of bangla montgomery asberg depression rating scale (MADRSB). Asian J Psychiatr. 2017;28:41–46.
   PubMed Web of Science ®Google Scholar
• Kang SS, Wong PWK. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis. 1996;119(2):135–138.
   PubMed Web of Science ®Google Scholar
• Guidara W, Messedi M, Naifar M, et al. Predictive value of oxidative stress biomarkers in drug-free patients with schizophrenia and schizo-affective disorder. Psychiatry Res. 2020;293:113467.
   PubMed Web of Science ®Google Scholar
• Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994;233:357–363.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304–1313.
   PubMed Web of Science ®Google Scholar
• Jollow D, Mitchell JR, Zampaglione N, et al. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974;11(3):151–169.
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with ellman’s reagent. Anal Biochem. 1968;25:192–205.
   PubMed Web of Science ®Google Scholar
• Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179(4073):588–590.
   PubMed Web of Science ®Google Scholar
• Płonka-Półtorak E, Zagrodzki P, Chłopicka J, et al. Valproic acid modulates superoxide dismutase, uric acid-independent FRAP and zinc in blood of adult epileptic patients. Biol Trace Elem Res. 2011;143(3):1424–1434.
   PubMed Web of Science ®Google Scholar
• Mazzara S, Rossi RL, Grifantini R, et al. CombiROC: an interactive web tool for selecting accurate marker combinations of omics data. Sci Rep. 2017;7:45477.
   PubMed Web of Science ®Google Scholar
• El-Ansary A, Bjørklund G, Chirumbolo S, et al. Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder. Metab Brain Dis. 2017;32(4):1209–1221.
   PubMed Web of Science ®Google Scholar
• Rathnayake D, Chang T, Udagama P. Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study. BMC Neurol. 2019;19(1):6.
   PubMedGoogle Scholar
• Shao L, Martin MV, Watson SJ, et al. Mitochondrial involvement in psychiatric disorders. Ann Med. 2008;40(4):281–295.
   PubMed Web of Science ®Google Scholar
• Kim Y, Vadodaria KC, Lenkei Z, et al. Mitochondria, metabolism, and redox mechanisms in psychiatric disorders. Antioxidants and Redox Signaling. 2019;2019:606.
   Google Scholar
• Dhama K, Latheef SK, Dadar M, et al. Biomarkers in stress related diseases/disorders: diagnostic, prognostic, and therapeutic values. Front Mol Biosci. 2019;6:91.
   PubMed Web of Science ®Google Scholar
• Nucifora LG, Tanaka T, Hayes LN, et al. Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry. Transl Psychiatry. 2017;7(8):e1215–e1215.
   PubMedGoogle Scholar
• Hatch J, Andreazza A, Olowoyeye O, et al. Cardiovascular and psychiatric characteristics associated with oxidative stress markers among adolescents with bipolar disorder. J Psychosom Res. 2015;79(3):222–227.
   PubMed Web of Science ®Google Scholar
• Magalhães PVS, Jansen K, Pinheiro RT, et al. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int J Neuropsychopharmacol. 2012;15(8): 43–50.
   Web of Science ®Google Scholar
• Lv Q, Guo Y, Zhu M, et al. Predicting individual responses to lithium with oxidative stress markers in drug-free bipolar disorder. World J Biol Psychiatry. 2019;20(10):778.
   PubMed Web of Science ®Google Scholar
• Bengesser SA, Lackner N, Birner A, et al. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder – gender and obesity effects. J Affect Disord. 2015;172:367–374.
   PubMed Web of Science ®Google Scholar
• Salagre E, Vizuete AF, Leite M, et al. Homocysteine as a peripheral biomarker in bipolar disorder: a meta-analysis. Eur Psychiatr. 2017;43:81–91.
   PubMed Web of Science ®Google Scholar
• Erzin G, Kotan VO, Topçuoğlu C, et al. Thiol/disulphide homeostasis in bipolar disorder. Psychiatry Res. 2018;261:237–242.
   PubMed Web of Science ®Google Scholar
• Ranjekar PK, Hinge A, Hegde MV, et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res. 2003;121(2):109–122.
   PubMed Web of Science ®Google Scholar
• Bengesser SA, Lackner N, Birner A, et al. Mood stabilizers, oxidative stress and antioxidative defense in euthymia of bipolar disorder. CNS Neurol Disord Drug Targets. 2016;15(4):381–389.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Gildengers A, Rajji TK, et al. Oxidative stress in older patients with bipolar disorder. Am J Geriatr Psychiatry. 2015;23(3):314–319.
   PubMed Web of Science ®Google Scholar
• Tsai MC, Huang TL. Thiobarbituric acid reactive substances (TBARS) is a state biomarker of oxidative stress in bipolar patients in a manic phase. J Affect Disord. 2015;173:22–26.
   PubMed Web of Science ®Google Scholar
• Scola G, McNamara RK, Croarkin PE, et al. Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder. J Affect Disord. 2016;192:176–183.
   PubMed Web of Science ®Google Scholar
• Huang JTJ, Leweke FM, Oxley D, et al. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med. 2006;3(11):e428.
   PubMed Web of Science ®Google Scholar
• Murray J, Oquendo CE, Willis JH, et al. Monitoring oxidative and nitrative modification of cellular proteins; a paradigm for identifying key disease related markers of oxidative stress. Adv Drug Deliv Rev. 2008;60(13–14):1497–1503.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11(1):81–128.
   PubMed Web of Science ®Google Scholar
• Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.
   PubMed Web of Science ®Google Scholar
• Versace A, Andreazza AC, Young LT, et al. Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol Psychiatry. 2014;19(2):200–208..
   PubMed Web of Science ®Google Scholar
• Newton DF, Naiberg MR, Andreazza AC, et al. Association of lipid peroxidation and Brain-Derived neurotrophic factor with executive function in adolescent bipolar disorder. Psychopharmacology. 2017;234(4):647–656.
   PubMed Web of Science ®Google Scholar
• Marsche G, Frank S, Hrzenjak A, et al. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res. 2009;104(6):750–757.
   PubMed Web of Science ®Google Scholar
• Morris G, Walder K, Carvalho AF, et al. The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases. Neurosci Biobehav Rev. 2018;84:453–469.
   PubMed Web of Science ®Google Scholar
• Maes M, Landucci Bonifacio K, Morelli NR, et al. Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder. Mol Neurobiol. 2019;56(1):141–156.
   PubMed Web of Science ®Google Scholar
• Ou H, Huang Z, Mo Z, et al. The characteristics and roles of advanced oxidation protein products in Atherosclerosis. Cardiovasc Toxicol. 2017;17(1):1–12.
   PubMed Web of Science ®Google Scholar
• Aldini G, Dalle-Donne I, Facino RM, et al. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev. 2007;27(6):817–868.
   PubMed Web of Science ®Google Scholar
• Barreiro E. Role of protein carbonylation in skeletal muscle mass loss associated with chronic conditions. Proteomes. 2016;4(2):18.
   Web of Science ®Google Scholar
• Nyström T. Role of oxidative carbonylation in protein quality control and senescence. Embo J. 2005;24(7):1311–1317.
   PubMed Web of Science ®Google Scholar
• Ciolino HP, Levine RL. Modification of proteins in endothelial cell death during oxidative stress. Free Radic Biol Med. 1997;22(7):1277–1282.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Sulochana KN, Lakshmi S, et al. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys. 2006;43(5):275–283.
   PubMed Web of Science ®Google Scholar
• Ho PI, Ortiz D, Rogers E, et al. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res. 2002;70(5):694–702.
   PubMed Web of Science ®Google Scholar
• Dimitrova KR, DeGroot KW, Suyderhoud JP, et al. 17-β Estradiol preserves endothelial cell viability in an in vitro model of homocysteine-induced oxidative stress. J Cardiovasc Pharmacol. 2002;39(3):347–353.
   PubMed Web of Science ®Google Scholar
• Power JHT, Blumbergs PC. Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of lewy bodies in Parkinson’s disease and dementia with lewy bodies. Acta Neuropathol. 2009;117(1):63–73.
   PubMed Web of Science ®Google Scholar
• Lu SC. Glutathione synthesis. Biochimica et Biophysica Acta - General Subjects. 2013;1830(5):43–53.
   Web of Science ®Google Scholar
• Wu G, Fang Y-Z, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489–492.
   PubMed Web of Science ®Google Scholar
• Gomez-Cabrera MC, Salvador-Pascual A, Cabo H, et al. Redox modulation of mitochondriogenesis in exercise. Does antioxidant supplementation blunt the benefits of exercise training? Free Radic Biol Med. 2015;86:37–46.
   PubMed Web of Science ®Google Scholar